Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - TOTAL CURRENT LIABILITIES
Total Current Liabilities LRMR - Larimar Therapeutics, Inc.
9.51 M
LAST VALUE
3.66%
2 YEAR CAGR
-6.50%
5 YEAR CAGR
12.55%
10 YEAR CAGR